ABSTRACT: Background: The emphasis regarding intracranial neuroendoscopy has been traditionally advocated and focused on the role in pediatric patients, although a significant usage has developed in adult patients. In this study, we examine and contrast the role of predominantly intracranial neuroendoscopy in both a pediatric and adult population with a minimum postprocedure follow-up of 5 years. Methods: A retrospective review was conducted for patients in the two hospitals that manage neurosurgical care for Southern Alberta, Canada, undergoing neuroendoscopic surgery between 1994 and 2008. The pediatric group was defined as age ≤17 years and the adult group as age ≥18 years. Results: A total of 273 patients who underwent a total of 330 procedures with a mean postprocedure follow-up of 12.9 years were identified. There were 161 adult and 112 pediatric patients, and both groups underwent surgery by the same surgeons. The most common procedure was endoscopic third ventriculostomy, accounting for 55% of procedures. One postoperative death occurred in an adult patient. Endoscopic third ventriculostomy success 1-year postprocedure was 81%, with only three late-term failures. Postoperative infection was the most common serious complication (two pediatric/four adult patients). Adult and pediatric patients had similar major complication rates (4.2% vs 5.7%, p = 0.547). Conclusions: Neuroendoscopy overall had a similar role in both pediatric and adult neurosurgical populations, with the most commonly associated complication being infection. Neuroendoscopy is an important therapeutic modality in the management of appropriate adult patients.
Neuroendoscopy is an important minimally invasive technique in neurosurgery 1 and has evolved to include a role in both the diagnosis and treatment of a variety of disorders. 2 In a historical context, the first therapeutic neuroendoscopic case was reported in Chicago in 1910, when L'Espinasse used a cystoscope to fulgurate the choroid plexus of two infants with hydrocephalus. 3 Choroid plexus cauterization for the treatment of hydrocephalus gained popularity in the 1930s, 4 followed by endoscopic third ventriculoscopy (ETV) in the 1960s. 5 However, it was not until the 1990s that endoscopy began to establish itself as a routine neurosurgical procedure. 6 It grew from purely intraventricular applications to include surgery within other fluid-filled cavities such as the cisterna magna and the spinal canal, and eventually outside the cranial space to include skull base surgery, 7 tumor biopsy and resection, exploration of the cerebellopontine angle, and treatment of craniosynostoses. 8, 9 Neuroendoscopy may be done via existing anatomical pathways (e.g. transnasal) or using transcortical single-or multiport systems, in addition to robotic applications. 10, 11 As experience grows and techniques are refined, complication rates are decreasing and more and more neurosurgeons are enticed by the less-invasive appeal of the neuroendoscope. However, despite these advances and novel initiatives to train growing numbers of surgeons in the proper use of this technique, 12, 13 intracranial neuroendoscopy is still seen as a pediatric neurosurgery procedure, even though there are numerous indications in adult patients. We report a large series of neuroendoscopic cases in which the same surgeons performed both adult and pediatric procedures to illustrate the similarities and differences between pediatric and adult patient populations.
METHODS
Following institutional board approval (E-22666), a retrospective chart review was performed for all patients who underwent neuroendoscopic surgery at the Foothills Medical Centre and the Alberta Children's Hospital between 1994 and 2008, as identified from a patient-specific database. These two hospitals are tertiary care centers providing care to all neurosurgical patients in Southern Alberta and parts of South-Eastern British Columbia (population approximately 1.5 million). We excluded transnasal pituitary and skull base procedures.
Information was collected from operative reports, clinic notes, progress notes in hospital, and discharge summaries. Recorded data included patient demographics, presenting symptoms, procedures performed, complications, and follow-up times. Pediatric patients were defined as age ≤17 years; adult patients were defined as age ≥18 years. Major complications included death, permanent neurological deficit or endocrine abnormality, meningitis, and a subdural collection requiring shunting. Minor complications included cerebrospinal fluid (CSF) leak, seizure, wound infection, and transient neurological deficit or endocrine abnormality.
Statistical analysis was performed using the R programming environment (Vienna, Austria). A p value of less than 0.05 was predefined to indicate a statistically significant result.
RESULTS
A total of 330 procedures were performed in 273 consecutive patients between 1994 and 2008; these comprised 141 procedures in 112 pediatric patients and 189 procedures in 161 adult patients. Both adult and pediatric cases were performed by the same surgeons. ETV was the most common procedure performed in both groups. As expected from disease presentations and characteristics, more colloid cysts were resected in adults and more arachnoid cysts were fenestrated in children. Mean followup duration after the neuroendoscopic procedure was 12.9 years (range 5.7-19.7 years excluding one early death) and median follow-up 12.8 years.
A breakdown of the adult procedures and their complications is shown in Table 1 . As seen in the table, ETV was the most common procedure performed in adult patients, followed by colloid cyst resection, tumor biopsy, and cyst fenestration. Major complications occurred in eight of 189 procedures, giving a major complication rate of 4.23%. These included four cases of meningitis and three cases of permanent neurological deficit, which included one postoperative case of hemiparesis, one cranial nerve palsy, and one patient who developed chronic seizures. In addition, one death occurred following septostomy in a 55-year-old man with a ventriculoperitoneal shunt. His shunt failed because of ventriculitis and a cerebellar abscess, and following the urgent removal of the shunt, a septostomy, and placement of an extraventricular drain, he developed a large intracerebral hemorrhage around the drain. Given his overall poor state, care was withdrawn.
A breakdown of the pediatric procedures and their complications is shown in Table 2 . As seen in the table, ETV was the most common procedure performed in pediatric patients, followed by cyst fenestration. Major complications occurred in eight of 141 procedures, giving a major complication rate of 5.67%. These included two cases of meningitis, two patients who developed permanent and severe weight gain, one patient with panhypopituitarism, one patient with severe memory impairment, and two patients who developed subdural collections that required shunting.
A breakdown of all minor complications in both pediatric and adult patients is shown in Table 3 . Minor complications occurred in 27 of 330 total procedures, giving an overall minor complication rate of 8.18%. The most common of these were CSF leak and transient seizures, followed by wound infection, transient weight gain or electrolyte abnormality, and transient cranial nerve III palsy.
We have previously reported the success of ETV to treat hydrocephalus as defined by remaining shunt-free at 1 year postprocedure 14 with rates of 82.5% for primary ETV and 82% for ETV done in the setting of shunt failure and subsequent shunt removal. The success rate for this expanded population is essentially unchanged (81%), and only three delayed failures of ETV have occurred with long-term follow-up. All three delayed failures occurred in patients who underwent their ETV when younger than age 18. Two occurred within 2 years and one 10 years post-ETV as an adult. All underwent successful repeat ETV procedures and remain shunt-free. To determine if there was a difference in the incidence of complications between adult and pediatric patients undergoing specific neuroendoscopic procedures, two-tailed chi-square tests were applied to major complication rates for each type of procedure, but none reached statistical significance (Table 4) , nor did the overall complication rate between adult and pediatric patients (4.2% vs 5.7%, p = 0.547).
Univariate logistic regression analysis was used to attempt to identify any specific procedures that may potentially be associated with major complications, and to determine if there was a relation between patient age and complication rates, but neither reached statistical significance (odds ratios, 0.62-1.43; p values, 0.22-0.79).
DISCUSSION
As minimally invasive approaches grow in popularity, endoscopy is becoming a powerful tool in the neurosurgeon's armamentarium. 15 However, despite the appeal of a smaller incision, and the now well-described anatomy of intraventricular spaces, 16, 17 serious perioperative complications may occur. This is largely due to the proximity of the endoscope to critical neural structures, as is the case in several endoscopic procedures. 18, 19 However, the incidence of complications is low, as reported in our population-based study, and varies with operative indication as well as patient age. Despite our finding that there is no statistically significant difference in complication rates between adult and pediatric patients, neuroendoscopy maintains the reputation of being a largely pediatric technique.
This large study is the first, to our knowledge, to report on endoscopic cases wherein the same surgeons performed both the pediatric and adult procedures, allowing for a direct and meaningful comparison of complication rates between the two patient groups. It is also the first to provide significant long-term follow-up.
Here we discuss the complications and outcomes of neuroendoscopy through its currently established indications.
Hydrocephalus
Hydrocephalus is a heterogeneous group of disorders that spans a wide range of ages and symptom profiles. 20 As such, each patient requires an individualized diagnostic and treatment approach. Traditionally, the treatment of hydrocephalus involved ventricular shunting, but because of the tendency of those systems to fail over time, whether from shunt malfunction or infection, 21 endoscopic techniques are emerging as possible alternatives. These include ETV and septostomy, options that are most suitable for treating those patients with obstructive hydrocephalus. [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] ETV consists of creating a hole through the tuber cinereum in the floor of the third ventricle to allow CSF to flow into the interpeduncular and prepontine cisterns, thereby bypassing obstructions in the aqueductal area, 21, [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] whereas septostomy involves placing the hole in the septum pellucidum. Another postulated mechanism involves the restoration of the pulsatility of ventricular walls as a result of the stoma, an effect that may help restore CSF dynamics by driving CSF flow from the ventricular system into the subarachnoid space. 22 On occasion, both ETV and septostomy may be required for the same patient to treat hydrocephalus.
The overall success rate of ETV has been reported as high as 89%, 23 and possibly even higher in the subset of patients with aqueductal stenosis, 41 with most failures presenting in the first few weeks after surgery. 24 The long-term success for ETV in this pediatric and adult patient population was 81%. Various classification systems are emerging not only to help predict outcome after endoscopic procedures for hydrocephalus, but also to aid in the selection of appropriate patients to maximize positive outcomes. 25, [42] [43] [44] [45] The most common indication for ETV is aqueductal stenosis, either from congenital narrowing of the aqueduct or obstructive tumors such as tectal gliomas 46 and obstructive cysts. 47, 48 Other indications include the fenestration of loculated compartments, 49, 50 ventriculoperitoneal shunt malfunction, 26, 27 and preresectional ETV for posterior fossa tumors. 51 Yet another potential role for ETV is in the realm of communicating hydrocephalus 52 -specifically normal pressure hydrocephalus 53, 54 -although these remain controversial indications. A recent randomized, open-label trial of 42 patients with normal pressure hydrocephalus found that those treated with a ventriculoperitoneal shunt had significantly better neurological outcomes at 12 months compared with those who underwent ETV (77% vs 50%), 55 whereas a large population-based study using institutional data found that ETV is associated with greater perioperative mortality and complication rates in these patients compared with shunting. 56 Although more needs to be learned about this patient population, and the benefits of ETV seem inferior to shunting in hydrocephalic people with normal or low pressures, it may still play a role in appropriately selected patients. 57 Appropriate candidates for ETV include both adults and children, although infants younger than 1 year old tend to have worse outcomes, 23,58-62 especially if they are born preterm or with a low birth weight. 63 Our series only had 34 children younger than 1 year of age undergoing a neuroendoscopic procedure, and only 14 underwent ETV. Complication rates in our pediatric population differed slightly from the literature in that, whereas overall trends showed complication rates increased with decreasing age, the highest rates of complication occurred in the 5-to 10-year-old age range.
In our series, 182 third ventriculostomies and 15 septostomies were performed; of these 197 procedures, 80 were performed on pediatric patients and 117 on adult patients. The overall major complication rate was 5.6%, which is similar to that of other studies. A recent systematic review by Bouras and Sgouros examined 2985 ETV procedures and reported an overall complication rate of 8.5%, a permanent morbidity rate of 2.4%, and a mortality rate of 0.21%. 64 Jenkinson reported a 5.8% complication rate in 190 adult ETV procedures 65 and Kadiran described a 4.9% infection rate, 7.2% transient major complication rate, and a 1.1% permanent complication rate in 203 ETV patients. 23 In general, it has been reported that complication and mortality rates decrease with increased surgeon experience and are lower compared with open procedures in experienced hands. 47, 66, 67 A qualitative analysis of our study did show that complication rates marginally decreased as surgeon experience increased, but it is important to note that equipment quality also improved over the course of the series. There were also more adult cases done later in the series, which may have contributed to the lower, albeit nonsignificant, complication rate in adult versus pediatric patients (4.2% vs 5.7%).
In addition, complications have been reported to occur more frequently in previously shunted patients than in patients treated for newly diagnosed hydrocephalus 14 as well as patients undergoing repeat procedures. 14, 68 However, many of these complications are classified as minor, are transient, and may not affect long-term outcome. Therefore, when assessing the risks versus benefits of performing ETV in previously shunted patients, it is important to take into consideration the natural history of these patients when using a shunt, and subsequently their cumulative risk of shunt revision and infection over the lifespan of the shunt.
Overall, the complication rate for ETV is low and is similar to the expected infection rate associated with shunts.
14 Although the potential exposure to significant neurological complications with ETV may be higher than the risk of a single shunt operation, the possibility of achieving long-term shunt independence with ETV should be considered preferable in good-risk patients when compared with the cumulative morbidity of multiple shunt procedures. 67 Absolute contraindications to ETV include small ventricular size preventing safe intraventricular manipulation of the scope and a tumor obstructing the surgeon's access to the floor of the third ventricle. 69 These scenarios aside, the difficulties inherent to pediatric endoscopy and the risks associated with more complex cases may be alleviated with the use of neuronavigation, a technique that has been shown to a safe and beneficial adjunct to endoscopy. [70] [71] [72] Several systems, such as AxiEM (Medtronic, USA) currently used at our center, allow frameless navigation of the endoscope in patients that are unable to safely undergo rigid cranial fixation in pins because of young age or thin skull vaults, and in the subset of patients who have complicated or distorted ventricular anatomy.
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Tumors
Endoscopic tumor management is a safe and effective alternative to conventional means and allows the option of ETV or septostomy for treatment of associated hydrocephalus. [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] The results in most series are based on data from both adult and pediatric populations. Neuroendoscopy in the field of neurooncology offers the advantages of improved visualization of intraventricular pathology, better management of tumor-related hydrocephalus, less morbid biopsies, and the allowance of minimally invasive removal of intraventricular tumors. 77, 91 Certain characteristics make a tumor ideally suited for endoscopic biopsy or resection. 78 These include moderate to low vascularity, soft-consistency, tumors smaller than 2 cm in diameter, those associated with secondary hydrocephalus, those that are histologically low grade, and lesions situated in the lateral ventricle and pineal region. 76, 92 In addition, tumors that will be treated primarily nonsurgically, such as gliomas of the tectal region, are ideally suited for primary treatment of obstructive hydrocephalus and, if appropriate, neuroendoscopic biopsy. 77 In our series, 27 intraventricular tumors were biopsied, four of which were also resected. Of the 27 patients, there were 20 adults and seven pediatric patients. The overall major complication rate was 3.7%, which is consistent with that of other series. Constantini et al reported a large series of 293 patients who underwent endoscopic tumor biopsy with an infection rate of 3% and a mortality rate of 0.3%. 93 Another report by Luther et al of 86 intraventricular tumors that were biopsied or resected had a hemorrhagic sequelae rate of 3.5%. 79 They defined clinically significant hemorrhage as that resulting in abandonment of the procedure, postoperative hydrocephalus requiring shunting, neurological change, or hemorrhage that required a second procedure to treat the bleed. In addition, Tirakotai et al described 46 patients (mean age 43.8 years) with peri-and intraventricular tumors who underwent neuroendoscopic procedures with three transient morbidities and one permanent deficit, but no operative mortality. 81 
Arachnoid Cysts
Primary arachnoid cysts are developmental lesions containing a fluid similar to CSF and are often incidentally found in patients as a focal area of fluid accumulation with bulging and thinning of the adjacent skull. 94 Overall, arachnoid cysts account for approximately 1% of all intracranial mass lesions, with potentially up to 60-90% of these becoming symptomatic in childhood. 95 Patients presenting with symptoms or signs of increased intracranial pressure or seizures and with growing arachnoid cysts are typically considered for surgical treatment. Endoscopic surgery has become the treatment of choice when feasible because of its minimal invasiveness and good outcomes. [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] Assessment of the anatomical relationship between the arachnoid cyst wall and adjacent anatomical structures such as blood vessels, cranial nerves, and brain parenchyma is necessary during preoperative planning to avoid injury to these structures. Complications may include intraoperative bleeding obscuring the surgeon's visual field, postoperative subdural hematomas or hygromas, meningitis, or the injuring of adjacent structures during fenestration. 106 In our combined series, 53 cyst fenestrations were performed, 16 in adults and 37 in pediatric patients. The overall major complication rate was 7.5%, which is similar to that of other series. For example, Nowoslawska et al reviewed 106 children with arachnoid cysts, 44 of whom underwent a neuroendoscopic procedure and 62 of whom underwent other operations. 101 Eleven of the 44 experienced complications, including five CSF leaks, two third nerve palsies, two subdural hematomas, one case of meningitis, and one case of severe intraoperative bleeding. In the nonendoscopic group, there were ten with complications. In a smaller series reported by Huang et al of 15 patients who underwent neuroendoscopic arachnoid cyst fenestration, there was only one complication of chronic subdural hematoma that was treated with burr hole drainage. 100 The authors concluded that, compared with traditional treatments, neuroendoscopic cystic fenestration is more effective and minimally invasive with less mortality and morbidity. Similarly, two additional patient series, one reported by Schroeder et al of 21 endoscopically fenestrated arachnoid cysts revealed no deaths or permanent complications 102 ; another study by Pradilla et al of 11 endoscopically treated arachnoid cysts (mean age 10.9 years) found one patient left with persistent spasticity and one patient suffering mild hemiparesis. 95 These authors concluded that cyst fenestration is favored over shunting as the method of choice for initial cyst decompression.
Colloid Cysts
Colloid cysts are benign space-occupying lesions that typically arise in the region of the anterior third ventricle 107 and represent about 0.5-2% of intracranial tumors. 108 Although uncommon, they are an important clinical entity because of their ability to cause CSF obstruction at the foramina of Munro with resultant hydrocephalus, which in the acute state can lead to sudden death. 108 If the obstruction of the foramina of Monro is asymmetrical, one lateral ventricle can grow larger than the other, resulting in bowing of the septum pellucidum to the nonaffected side. 109 Although microsurgery has been the classic treatment option, 110 the composition and location of these cysts make them ideally suited for endoscopic excision. [111] [112] [113] [114] [115] Expectedly, the success of endoscopic colloid cyst removal is heavily dependent upon the surgeon's experience. 77 In our series, 32 colloid cysts were endoscopically resected, 31 of which were in adult patients. The overall major complication rate was 3.1%, and the cyst recurred in one case. We have previously presented our data in comparison to microsurgical resections, showing that endoscopic resection of colloid cysts can be performed with a significantly lower risk of complications than microsurgical resection (4% vs 33%), and with equivalent surgical success. 108 In addition, operative time and length of hospital stay are both significantly reduced with endoscopic resection. Similar results were found in a series of 30 patients reported by Lewis et al, 116 where half underwent open resection and the other half endoscopic resection of a colloid cyst. They found the endoscopic group had shorter hospital stay and operative time, as well as a shorter interval before returning to work. Similarly, Longatti et al reported on 61 patients (mean age 41 years) undergoing endoscopic colloid cyst resection who had a complication rate of 3.2%, with seven asymptomatic recurrences, 110 and Greenlee et al reported 35 patients (mean age 32.4 years) experiencing a complication rate of 8.6%. 117 
SUMMARY AND CONCLUSIONS
Intracranial, intraventricular neuroendoscopy was performed in 161 adult and 112 pediatric patients. A higher percentage of pediatric patients underwent cyst fenestration, whereas a higher percentage of adults underwent ETV, colloid cyst removal, and tumor biopsy. The most common complication associated with neuroendoscopy was infection, and adult and pediatric patients had similar complication rates. These findings highlight the important potential role for neuroendoscopy during management of appropriate adult patients. Therefore, neuroendoscopy should be an available therapeutic modality in all neurosurgical centers and should be considered as a potential therapeutic modality in the management of suitable adult as well as pediatric patients.
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